[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620056":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":22,"centralContacts":25,"locations":31,"responsibleParty":43,"collaborators":47,"id":50,"slug":22,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":22,"enrollmentInfo":58,"targetDuration":22,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":22,"overallStatus":68,"whyStopped":22,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Beth Israel Deaconess Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Guideline-based Care","ACTIVE_COMPARATOR","Remote monitoring programming scheduled for alert transmissions, patient-initiated transmissions, and routine transmissions (scheduled to occur every 90 days from the date of enrollment in the study); in-office interrogations on at least an annual basis",[13],"Other: Guideline-based Care",{"label":15,"type":10,"description":16,"interventionNames":17},"Alert-based care","Alert-based care is an alternative strategy for longitudinal management of patients with wireless pacemakers and implantable defibrillators",[18],"Other: Alert-based care",[20,23],{"type":6,"name":15,"description":16,"armGroupLabels":21,"otherNames":22},[15],null,{"type":6,"name":9,"description":11,"armGroupLabels":24,"otherNames":22},[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":22,"email":30},"Daniel B Kramer, MD, MPH","CONTACT","617-667-8800","dkramer@bidmc.harvard.edu",[32],{"facility":5,"status":22,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":22},"Boston","Massachusetts","02215","United States",{"type":38,"coordinates":39},"Point",[40,41],-71.05977,42.35843,{"lat":41,"lon":40},{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"PRINCIPAL_INVESTIGATOR","Daniel B. Kramer","Associate Professor of Medicine",[48],{"name":49,"class":6},"Patient-Centered Outcomes Research Institute","100620056",false,"NCT07352657","Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase)","RAPTOR - MAIN","Inclusion Criteria:\n\n1. Adult aged \\> 18 years\n2. Clinically stable by investigator assessment\n3. Has a newly implanted or existing wireless CIED: single, dual-chamber, biventricular, subcutaneous\u002Fextravascular, and leadless systems are all eligible, including pacemakers or implantable cardioverter-defibrillators (ICDs)\n4. CIED is from one of the 4 major CIED manufacturers in the US market (99% of implants in the US): Medtronic, Boston Scientific, Abbott, Biotronik\n5. Currently enrolled in remote monitoring as part of standard of care\n6. Primary clinical electrophysiology follow-up at the enrolling center\n7. Understands spoken and written English, Spanish, or Portuguese\n8. Has sufficient cognitive function to answer standardized questions about study rationale and procedures.\n\nExclusion Criteria:\n\n1. Presence of insertable cardiac monitor, either in isolation or in combination with any other CIED\n2. Listed for cardiac transplantation prior to enrollment (N.B. if a patient becomes listed for transplantation during the study, they may continue study participation)\n3. Participation in another study related to novel CIED technology or remote monitoring.","ALL","18 Years",{"count":59,"type":60},3000,"ESTIMATED","INTERVENTIONAL",[63],"NA","he Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs).\n\nThe study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Main Phase of the study.",[66,67],"Pacemaker","Implantable Defibrillator","NOT_YET_RECRUITING","2026-02-04",{"date":71,"type":72},"2026-02-06","ACTUAL",{"date":74,"type":60},"2026-12-01",{"date":76,"type":60},"2031-01-31",{"name":5,"class":6},1]